Theis FJ, Corbacioglu A, Gaidzik VI, Paschka P, Weber D, Bullinger L, Heuser M, Ganser A, Thol F, Schlegelberger B, Goehring G, Koehne CH, Germing U, Brossart P, Horst HA, Haase D, Goetze K, Ringhoffer M, Fiedler W, Nachbaur D, Kindler T, Held G, Luebbert M, Wattad M, Salih HR, Krauter J, Doehner H, Schlenk RF, Doehner K (2016)
Publication Type: Journal article
Publication year: 2016
Book Volume: 30
Pages Range: 2248-2250
Journal Issue: 11
DOI: 10.1038/leu.2016.185
APA:
Theis, F.J., Corbacioglu, A., Gaidzik, V.I., Paschka, P., Weber, D., Bullinger, L.,... Doehner, K. (2016). Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group. Leukemia, 30(11), 2248-2250. https://doi.org/10.1038/leu.2016.185
MLA:
Theis, Fabian J, et al. "Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group." Leukemia 30.11 (2016): 2248-2250.
BibTeX: Download